Clinical trial Recruiting at 1 site Interventional Ages 55 and up

Cross-modal cerebellar stimulation to improve balance and vision in glaucoma

Official title: Cross-modal Neuromodulation to Improve Balance and Cognition in Older Adults With Glaucoma: A Randomized Trial of Cerebellar Transcranial Electrical Stimulation

Run by The Hong Kong Polytechnic University · NCT07771699 · Data updated 2026-11-12

In older adults with glaucoma, this study tests whether different cerebellar transcranial electrical stimulation methods can improve balance and visual-cognitive function.

Quick facts

Study typeInterventional
Ages55 Years and up
SexAll
Enrollment36 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Kowloon, Hong Kong)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedNovember 1, 2029
Study endsNovember 1, 2029
Registry record updatedAugust 18, 2026
Trial IDNCT07771699 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 55 with open-angle or normal-tension glaucoma, measurable visual field loss, adequate daytime vision, preserved general cognition, and right-handedness.

Probably not a fit

Patients with additional ocular diseases, significant hearing impairment, or contraindications to transcranial electrical stimulation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, sham-controlled, cross-over trial will compare two cerebellar tES techniques (tDCS and tACS) against sham stimulation in adults over 55 with glaucoma. Participants receive 15 stimulation sessions across 3 blocks, with balance and visual-cognitive assessments before and after each session. The design aims to see if cerebellar stimulation produces longer-term improvements in balance and visual attention beyond short-term effects. The study leverages a within-subject approach to reduce variability and enhance detection of any treatment effects.

Why it matters

Potential benefit: If successful, patients could gain better balance and sharper visual-cognitive function, potentially lowering fall risk and improving daily activities.

How similar studies have gone: Previous research suggests cerebellar stimulation can influence balance; this study explores a novel, combined approach in glaucoma patients.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age over 55 years old;
* Diagnosis of primary open-angle or normal-tension glaucoma with relative scotoma in both eyes;
* Humphrey Field Analyzer visual field loss (mean deviation of ≤- 6 dB) using the 24-2 testing protocol for both eyes;
* Best-corrected distance visual acuity of 6/12 (equivalent to 0.3 logMAR) or better;
* Cognitive functional score of 22 or above in the Montreal Cognitive Assessment -Hong Kong version (HK-MoCA).
* Only the right-handed population will be recruited (screening by the Edinburgh Handedness Inventory).

Exclusion Criteria:

* Have musculoskeletal disorders or neurological diseases that can affect the balance or nervous system.
* Ocular diseases other than glaucoma (e.g., age-related macular degeneration, diabetic retinopathy, moderate to severe cataract) or severe hearing impairment (to ensure that participants can hear the instructions clearly during assessments and training)
* Have any contraindications for tES

Where it's running

  • Hong Kong Polytechnic University
    Kowloon, Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.